Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Nov 18, 2019 2:29pm

112 Views

Post# 30365890

RE:RE:McGill and London - Status

Makes one wonder why no patients have been treated at these locations. It is pretty basic who qualifies. Shouldn't take endless months to set up. With such a slow process, it is hard to see this stock above it's current levels for many months... or a couple of years. Slow process..but hanging in with my shares.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading